Miami Cancer Institute Research

1.2K posts

Miami Cancer Institute Research

@MiamiCancerInst

Providing quality cancer care in South Florida and aiming for innovative research excellence, part of @BHCancerCare | @BaptistHealthSF

South Florida Katılım Ekim 2022

551 Takip Edilen899 Takipçiler

Miami Cancer Institute Research@MiamiCancerInst·7 May

We're proud to recognize Dr. Kyaw Aung, co-author of a landmark publication in The New England Journal of Medicine evaluating daraxonrasib in previously treated advanced RAS-mutated pancreatic ductal adenocarcinoma. @NEJM nejm.org/doi/full/10.10…

English

300

Miami Cancer Institute Research@MiamiCancerInst·7 May

Congratulations to Dr. Kyaw Aung and fellow investigators on this landmark publication in @NEJM highlighting the high-impact potential of #daraxonrasib in pancreatic cancer.

NEJM@NEJM

New in the May 7, 2026, issue of NEJM: Left Ventricular Unloading in High-Risk PCI (CHIP-BCIS3 trial) nej.md/4lR1vyX Daraxonrasib in RAS-Mutated Pancreatic Cancer nej.md/4f7xfhX An mRNA Seasonal Influenza Vaccine in Adults (phase 3 Fluent trial) nej.md/4nfu2z8 Ivermectin and 5% Permethrin Cream for Severe Scabies (GALE CRUSTED trial) nej.md/4tDGSsF Base Editing of HBG1 and HBG2 Promoters for SCD nej.md/3NZbo13 Subscribe to NEJM for the latest medical research: nej.md/3spfZ1z

English

205

Miami Cancer Institute Research@MiamiCancerInst·7 May

@NEJM Congratulations to Dr. Kyaw Aung and fellow investigators on this landmark publication in @NEJM highlighting the high-impact potential of #daraxonrasib in pancreatic cancer.

English

NEJM@NEJM·7 May

English

5.4K

Miami Cancer Institute Research retweetledi

Sarbajit Mukherjee@Sarbaji85064063·28 Nis

Grateful to @FoxNews for allowing me to share my thoughts on pancreatic cancer and on a drug that may meaningfully extend survival for patients. For decades, KRAS was the “undruggable” engine of PDAC. Seeing RAS-directed therapies finally move the needle is a watershed moment for our field. At @MiamiCancerInst @BHCancerCare @BaptistHealthSF, we’re excited to build a precision-therapy clinical trials program so every GI cancer patient has a chance to access molecularly targeted options close to home. noticias.foxnews.com/health/pancrea… #PancreaticCancer #GIOnc #PrecisionOncology #KRAS #ClinicalTrials #RASOn

English

601

Miami Cancer Institute Research@MiamiCancerInst·1 May

Key Cancer Insights during the @BaptistHealthSF Biomedical Research Symposium | moderated by Dr. Manmeet Ahluwalia (@BrainTumorDoc) ⬇️ Dr. Joseph Panoff shared data on targeted photon RT benefits vs proton therapy in reconstruction. Dr. Alessandro Villa (@villa_dds) explained chemoprevention for oral dysplasia. Dr. Noah Kalman discussed RT-related toxicities in head & neck cancer. Dr. Delia Constanza Guaqueta highlighted neoadjuvant endocrine therapy to downstage breast tumors. The discussions highlighted research translating into real-world impact for @BHCancerCare patients.

Miami Cancer Institute Research tweet media

English

363

Miami Cancer Institute Research@MiamiCancerInst·23 Nis

We’re proud to support the next generation of leaders in radiation oncology physics. Learn more about the #MedPhys residency here: bapth.lt/MedPhys

Baptist Health Academics@BHAcademics

We're pleased to welcome Cameron Hodges, MSc, to the Medical Physics Residency at @MiamiCancerInst. This two-year program provides advanced clinical training in radiation oncology physics, preparing residents for meaningful careers. Learn more: bapth.lt/MedPhys

English

154

Miami Cancer Institute Research@MiamiCancerInst·3 Nis

New data from @ASTRO_org #MRPTS26 presented by @Ganiyani_MD & @RohanGarjeMD reinforce the promise of 177Lu-PSMA-617 in advanced prostate cancer, showing a consistent ability to delay disease progression across randomized trials. Learn More 👇 x.com/MiamiCancerIns…

Miami Cancer Institute Research@MiamiCancerInst

x.com/i/article/2040…

English

439

Miami Cancer Institute Research@MiamiCancerInst·3 Nis

x.com/i/article/2040…

ZXX

519

Miami Cancer Institute Research@MiamiCancerInst·26 Mar

Dr. Guenther Koehne (@GuentherKoehne) emphasizes how quickly hematologic oncology is evolving and why clinicians need to stay current as standards of care continue to shift in a feature from @CancerNetwrk cancernetwork.com/view/what-s-th…

English

Miami Cancer Institute Research retweetledi

Targeted Oncology@TargetedOnc·11 Mar

💬 At @MiamiCancerInst's 7th Annual Immunotherapies Summit for Hematologic Malignancies, Dr Richard Stone @DanaFarber discussed new trial data that suggest aza-ven may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations. #Leukemia hubs.li/Q046k-sB0

English

249

Miami Cancer Institute Research@MiamiCancerInst·9 Mar

Thank you to all who contributed to such a dynamic exchange of ideas during the Seventh Annual Immunotherapies Summit for Hematologic Malignancies. Experts from leading institutions shared insights on CAR T-cell therapies, targeted treatments and evolving strategies shaping the future of leukemia, lymphoma and multiple myeloma.

English

316

Miami Cancer Institute Research@MiamiCancerInst·6 Mar

Emerging therapies for malignancies including DLBCL and CLL continue to evolve and improve outcomes. Thank you to Dr. Craig Sauter and Dr. Matthew Matasar for sharing their insights. #lymphoma #leukemia #leusm

English

118

Miami Cancer Institute Research@MiamiCancerInst·6 Mar

Last night’s welcome reception celebrating the seventh annual Immunotherapies Summit for Hematologic Malignancies included great conversations and inspiring remarks from @GuentherKoehne. Special thanks to our faculty, generous donors and exhibitors for their support!

English

248

Miami Cancer Institute Research@MiamiCancerInst·6 Mar

Great Q&A discussion during the Multiple Myeloma panel with thoughtful questions from attendees and experience-based insights from Drs. @szusmani, Cohen, Richardson, Duarte, and Landau on how these evolving options translate into real-world decisions.

English

277

Miami Cancer Institute Research@MiamiCancerInst·6 Mar

It was a pleasure to host the next generation of physicians. Thank you Dr. Ahluwalia @braintumordoc for leading this visit!

FIU Medicine@FIUMedicine

Our med students toured @BaptistHealthSF Miami Cancer Institute for an inspiring Q&A with its deputy director & FIU Professor Dr. Manmeet Ahluwalia. They got advice on oncology careers and residency applications. Thanks to the @BHCancerCare team for welcoming our students!

English

367

Miami Cancer Institute Research retweetledi

Manmeet Ahluwalia, MD, MBA, FASCO@BrainTumorDoc·5 Mar

Thrilled to welcome @BrunaPellini as the Chief of Thoracic Oncology! She is a superstar and look forward to her leadership! Onwards and upwards!

Miami Cancer Institute Research@MiamiCancerInst

We are proud to welcome @BrunaPellini, M.D. as Chief of Thoracic Oncology. To schedule an appointment with Dr. Pellini, visit baptisthealth.net/doctors/bruna-…

English

Keşfet

@NEJM @FoxNews @BaptistHealthSF @BrainTumorDoc @villa_dds @ASTRO_org @Ganiyani_MD @RohanGarjeMD